SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
XAIR

Beyond Air, Inc. (NASDAQ:XAIR)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$1.54-$0.18 (-10.47%)
 
Market cap
$977K
Insider Score
Health Score
Analyst consensus
Listed since
Jun 12, 2018
Market Cap$977.34K-94.0%
Revenue (ttm)$8.19M+41.2%
Net Income-$33.37M+9.1%
EPS-$51.55+65.8%
Shares Out634.63K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume27,736
Open$1.65
Previous Close$1.72
Day's Range$1.54 - $1.67
52-Week Range$1.53 - $53.20
Beta0.15
AnalystsBuy
Price Target$10.00(+549.35%)
Earnings DateFeb 11, 2027
-9.88% (1D)
No price history available.

About XAIR

Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and bronchiolitis in hospital settings. It is also creating LungFit GO, which aims to treat nontuberculous mycobacteria infections. The organization adopted its current name, Beyond Air, Inc., in June 2019, having previously been known as AIT Therapeutics, Inc. Its headquarters are situated in Garden City, New York.

Address
900 Stewart Avenue, Garden City, NY, 11530, US
Market Cap
1 million
Employees
54
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$287.35K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Weak
From XAIR’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-10.47%
5 Days
-24.51%
1 Month
-33.04%
6 Months
-80.80%
1 Year
-93.98%

$XAIR stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in XAIR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by XAIR's directors and management

Net Shares Purchased by Insiders−50k−25k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

XAIR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New XAIR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to XAIR from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in XAIR

VXFVanguard Extended Market ETF$7.09K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from XAIR’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
45

News check: Record Q2 revenue and FDA review progress offset by regulatory referral for advertising noncompliance; mixed catalysts.

Recent Insider Activity

Buys
6
Sells
0
Buy Value
$287.35K
Distinct Buyers
3

Insider Score Trend Over Time

+68.6 since Oct 3
0255075100Oct 3 — Insider Score 0.0Oct 4 — Insider Score 71.3Oct 5 — Insider Score 71.2Oct 6 — Insider Score 70.3Oct 7 — Insider Score 70.0Oct 8 — Insider Score 69.8Oct 9 — Insider Score 69.5Oct 10 — Insider Score 69.1Oct 11 — Insider Score 70.1Oct 12 — Insider Score 70.1Oct 13 — Insider Score 69.8Oct 14 — Insider Score 69.4Oct 15 — Insider Score 69.5Oct 16 — Insider Score 69.0Oct 17 — Insider Score 69.0Oct 18 — Insider Score 69.3Oct 19 — Insider Score 69.2Oct 20 — Insider Score 69.3Oct 21 — Insider Score 69.0Oct 22 — Insider Score 69.1Oct 23 — Insider Score 69.2Oct 24 — Insider Score 69.0Oct 25 — Insider Score 68.6Oct 3Oct 14Oct 25

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.